Resultado da Busca
Há 1 dia · Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands Sabine H. Josemans & Joris I. Rotmans Imec, R&D and innovation hub in nanoelectronics and digital ...
Há 3 dias · Phase 1–2 trials involving patients with resectable, macroscopic stage III melanoma have shown that neoadjuvant immunotherapy is more efficacious than adjuvant immunotherapy.In this phase 3 ...
Há 2 dias · Between Jan 21, 2022, and Feb 21, 2023, 123 patients were randomly assigned (83 to vimseltinib and 40 to placebo). 73 (59%) patients were female and 50 (41%) were male.
Há 2 dias · In addition, blood samples are collected annually and stored in the Biobank Rheumatic Diseases of Leiden University Medical Center (LUMC). All patients who are registered in the CCISS cohort gave written informed consent to participate in studies concerning the Biobank Rheumatic diseases.
Há 5 dias · Center for Endocrine Tumors Leiden (CETL), Pituitary Center, Leiden University Medical Center, Leiden, The Netherlands. Correspondence Leontine E. H. Bakker, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands. Email: [email protected] Search for more papers by this author
Há 2 dias · “The results from the MOTION pivotal Phase 3 study provide compelling evidence that vimseltinib can address the unmet medical need in TGCT for an effective and well-tolerated therapy without cholestatic hepatotoxicity,” said Hans Gelderblom, M.D., Ph.D., Chair of the Department of Medical Oncology at Leiden University Medical Center and ...
Há 1 dia · Results. We included 61,853 individuals in the population-based cohort (median age 63 [quartiles 54–72] years) and 4,823 in the clinical cohort (median age 65 [quartiles 57–72] years). The incidence rate of hospital-diagnosed DPN in the population-based cohort was 3.6 per 1000 person-years during a median follow-up of 7.3 years.
